ASH1L inhibitors and methods of treatment therewith Grant US-11883381-B2 United States of America 30 Jan 2024
ASH1L inhibitors and methods of treatment therewith Grant US-11833210-B2 United States of America 05 Dec 2023
ASH1L degraders and methods of treatment therewith Grant US-11786602-B2 United States of America 17 Oct 2023
OLIGONUCLEOTIDES AND COMPOSITIONS THEREOF FOR NEUROMUSCULAR DISORDERS Application WO-2023288289-A2 World Intellectual Property Organisation (WIPO) 19 Jan 2023